Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model

被引:160
作者
Fukushima, Satsuki [1 ]
Varela-Carver, Anabel [1 ]
Coppen, Steven R. [1 ]
Yamahara, Kenichi [1 ]
Felkin, Leanne E. [1 ]
Lee, Joon [1 ]
Barton, Paul J. R. [1 ]
Terracciano, Cesare M. N. [1 ]
Yacoub, Magdi H. [1 ]
Suzuki, Ken [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, Harefield Heart Sci Ctr, London, England
基金
英国医学研究理事会;
关键词
arrhythmia; cell therapy; heart failure;
D O I
10.1161/CIRCULATIONAHA.106.662577
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background- Therapeutic efficacy of bone marrow ( BM) cell injection for treating ischemic chronic heart failure has not been established. In addition, experimental data are lacking on arrhythmia occurrence after BM cell injection. We hypothesized that therapeutic efficacy and arrhythmia occurrence induced by BM cell injection may be affected by the cell delivery route. Methods and Results - Three weeks after left coronary artery ligation, wild-type female rats were injected with 1 x 10(7) mononuclear BM cells derived from green fluorescent protein-transgenic male rats through either a direct intramyocardial or a retrograde intracoronary route. Both intramyocardial and intracoronary injection of BM cells demonstrated similar improvement in left ventricular ejection fraction measured by echocardiography and a similar graft size analyzed by real-time polymerase chain reaction for the Y chromosome - specific Sry gene. Noticeably, intramyocardial injection of BM cells induced frequent ventricular premature contractions ( 108 +/- 73 per hour at 7 days after BM cell injection), including multiform, consecutive ventricular premature contractions and ventricular tachycardia for the initial 14 days; intracoronary injection of BM cells and intramyocardial injection of phosphate-buffered saline rarely induced arrhythmias. Immunohistochemistry demonstrated that intramyocardial BM cell injection formed distinct cell clusters containing donor-derived cells and accumulated host-derived inflammatory cells in the infarct border zone, whereas intracoronary BM cell injection provided more homogeneous donor cell dissemination with less inflammation and without disrupting the native myocardial structure. Conclusions - BM cell injection is able to improve cardiac function in ischemic chronic heart failure but has a risk of arrhythmia occurrence when the intramyocardial route is used. Such arrhythmias may be prevented by using the intracoronary route.
引用
收藏
页码:2254 / 2261
页数:8
相关论文
共 37 条
[1]  
Beeres SLMA, 2006, J NUCL MED, V47, P574
[2]   Intracoronary administration of autologous bone marrow mononuclear cells after induction of short ischemia is safe and may improve hibernation and ischemia in patients with ischemic cardiomyopathy [J].
Blatt, A ;
Cotter, G ;
Leitman, M ;
Krakover, R ;
Kaluski, E ;
Milo-Cotter, O ;
Resnick, IB ;
Samuel, S ;
Gozal, D ;
Vered, Z ;
Slavin, S ;
Shapira, MY .
AMERICAN HEART JOURNAL, 2005, 150 (05) :986.e1-986.e7
[3]   Proarrhythmic potential of mesenchymal stem cell transplantation revealed in an in vitro coculture model [J].
Chang, MG ;
Tung, L ;
Sekar, RB ;
Chang, CY ;
Cysyk, J ;
Dong, PH ;
Marbán, E ;
Abraham, R .
CIRCULATION, 2006, 113 (15) :1832-1841
[4]   Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction [J].
Chen, SL ;
Fang, W ;
Ye, F ;
Liu, YH ;
Qian, J ;
Shan, S ;
Zhang, J ;
Zhao, RCH ;
Liao, LM ;
Lin, S ;
Sun, JP .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (01) :92-95
[5]   Rat models of hypertension, cardiac hypertrophy and failure [J].
Doggrell, SA ;
Brown, L .
CARDIOVASCULAR RESEARCH, 1998, 39 (01) :89-105
[6]   Autologous myoblast transplantation after myocardial infarction increases the inducibility of ventricular arrhythmias [J].
Fernandes, S ;
Amirault, JC ;
Lande, G ;
Nguyen, JM ;
Forest, V ;
Bignolais, O ;
Lamirault, G ;
Heudes, D ;
Orsonneau, JL ;
Heymann, MF ;
Charpentier, F ;
Lemarchand, P .
CARDIOVASCULAR RESEARCH, 2006, 69 (02) :348-358
[7]   The inflammatory response in myocardial infarction [J].
Frangogiannis, NG ;
Smith, CW ;
Entman, ML .
CARDIOVASCULAR RESEARCH, 2002, 53 (01) :31-47
[8]   Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease - A feasibility study [J].
Fuchs, S ;
Satler, LF ;
Kornowski, R ;
Okubagzi, P ;
Weisz, G ;
Baffour, R ;
Waksman, R ;
Weissman, NJ ;
Cerqueira, M ;
Leon, MB ;
Epstein, SE .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (10) :1721-1724
[9]   Skeletal myoblast transplantation in ischemic heart failure -: Long-term follow-up of the first phase I cohort of patients [J].
Hagege, Albert A. ;
Marolleau, Jean-Pierre ;
Vilquin, Jean-Thomas ;
Alheritiere, Armelle ;
Peyrard, Severine ;
Duboc, Denis ;
Abergel, Eric ;
Messas, Emmanuel ;
Mousseaux, Elie ;
Schwartz, Ketty ;
Desnos, Michel ;
Menasche, Philippe .
CIRCULATION, 2006, 114 :I108-I113
[10]   Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines [J].
Kamihata, H ;
Matsubara, H ;
Nishiue, T ;
Fujiyama, S ;
Tsutsumi, Y ;
Ozono, R ;
Masaki, H ;
Mori, Y ;
Iba, O ;
Tateishi, E ;
Kosaki, A ;
Shintani, S ;
Murohara, T ;
Imaizumi, T ;
Iwasaka, T .
CIRCULATION, 2001, 104 (09) :1046-1052